NeoGenomics Analyst Price Targets - Benzinga

NeoGenomics Inc

NEONASDAQ

Trade with Public

Trade with Public

$17.11

0.623.76%

Últ. Act.: Nov 3, 2:13 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

NeoGenomics Analyst Price Targets - Benzinga

NeoGenomics Analyst Price Targets

Wall Street analyst price targets and consensus rating for NeoGenomics (NEO).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

11Buy

2Hold

Consensus RatingBuy# Analysts13Avg. Consensus PT$18Upside to Avg. PT+4.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 29, 2026	TD Cowen	Dan Brennan	PT Raise	Buy	$19→$23
Oct 29, 2026	BTIG	Mark Massaro	Maintained	Buy	$28
Oct 6, 2026	StoneX	Bruce D. Jackson	PT Raise	Buy	$16→$20
Oct 6, 2026	Needham	Mike Matson	PT Raise	Buy	$19→$22
Oct 6, 2026	BTIG	Mark Massaro	Upgrade	Neutral→Buy	$28
Jul 29, 2026	Needham	Mike Matson	PT Raise	Buy	$15→$19
Jul 24, 2026	Benchmark	Bruce D. Jackson	PT Raise	Buy	$11→$16
Apr 29, 2026	Benchmark	Bruce Jackson	Upgrade	Hold→Buy	$11
Apr 29, 2026	TD Cowen	Dan Brennan	PT Raise	Buy	$13→$14
Apr 29, 2026	Leerink Partners	Puneet Souda	Upgrade	Market Perform→Outperform	$12→$25
Feb 24, 2026	Piper Sandler	David Westenberg	PT Raise	Overweight	$12→$13
Feb 17, 2026	Needham	Mike Matson	PT Raise	Buy	$14→$15
Jan 12, 2026	Needham	Mike Matson	Maintained	Buy	$14
Sep 12, 2025	TD Cowen	Dan Brennan	PT Raise	Buy	$10→$12
Sep 2, 2025	Stephens & Co.	Mason Carrico	PT Raise	Overweight	$7→$11
Aug 29, 2025	Needham	Mike Matson	PT Raise	Buy	$8→$14
Aug 4, 2025	Piper Sandler	David Westenberg	PT Cut	Overweight	$12→$11
Jul 30, 2025	Morgan Stanley	Tejas Savant	PT Cut	Equal-Weight	$10→$8
Jul 29, 2025	Needham	Mike Matson	PT Cut	Buy	$9→$8
Jul 29, 2025	William Blair	—	Downgrade	Outperform→Market Perform	—

Analyst Ratings News

PRO
TD Cowen Maintains Buy on NeoGenomics, Raises Price Target to $23

TD Cowen analyst Dan Brennan maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $19 to $23.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on NeoGenomics, Maintains $28 Price Target

BTIG analyst Mark Massaro reiterates NeoGenomics (NASDAQ:NEO) with a Buy and maintains $28 price target.

Benzinga Newsdesk

What's Going On With NeoGenomics Stock Tuesday?

NeoGenomics stock falls after leadership shuffle and Q3 preliminary results. Analysts weigh in on growth and valuation.

Vandana Singh

General Motors To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts raised targets for PTC, Cloudflare, PENN, Microsoft and others, while downgrading PTC and upgrading PENN and Abbott.

Avi Kapoor

PRO
StoneX Maintains Buy on NeoGenomics, Raises Price Target to $20

StoneX analyst Bruce D. Jackson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $16 to $20.

Benzinga Newsdesk

This Boyd Gaming Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Analysts upgraded Boyd Gaming, NeoGenomics, PENN Entertainment, XP and Rezolute, raising targets for several names.

Avi Kapoor